DAN A23 (Ranitidine Hydrochloride 300 mg)
Pill with imprint DAN A23 is Yellow, Elliptical/Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Schein.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis; gerd and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DAN A23
Ranitidine Hydrochloride
- Imprint
- DAN A23
- Strength
- 300 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schein
- National Drug Code (NDC)
- 00364-2634 (Discontinued)
More about ranitidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (156)
- Patient tips
- Drug images
- Compare alternatives
- Drug class: H2 antagonists
Patient resources
- Drug Information
- Ranitidine Injection
- Ranitidine Tablets and Capsules
- Ranitidine Suspension
- Ranitidine Syrup
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.